GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (FRA:8IN) » Definitions » EV-to-FCF

Syneos Health (FRA:8IN) EV-to-FCF : 42.71 (As of May. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syneos Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Syneos Health's Enterprise Value is €6,884 Mil. Syneos Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was €161 Mil. Therefore, Syneos Health's EV-to-FCF for today is 42.71.

The historical rank and industry rank for Syneos Health's EV-to-FCF or its related term are showing as below:

FRA:8IN' s EV-to-FCF Range Over the Past 10 Years
Min: 13.98   Med: 27.83   Max: 319.13
Current: 42.71

During the past 12 years, the highest EV-to-FCF of Syneos Health was 319.13. The lowest was 13.98. And the median was 27.83.

FRA:8IN's EV-to-FCF is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 25.03 vs FRA:8IN: 42.71

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Syneos Health's stock price is €40.00. Syneos Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.713. Therefore, Syneos Health's PE Ratio for today is 56.10.


Syneos Health EV-to-FCF Historical Data

The historical data trend for Syneos Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health EV-to-FCF Chart

Syneos Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.51 34.41 26.02 34.23 19.51

Syneos Health Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.54 21.61 19.51 21.42 40.94

Competitive Comparison of Syneos Health's EV-to-FCF

For the Diagnostics & Research subindustry, Syneos Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syneos Health's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Syneos Health's EV-to-FCF falls into.



Syneos Health EV-to-FCF Calculation

Syneos Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6883.958/161.195
=42.71

Syneos Health's current Enterprise Value is €6,884 Mil.
Syneos Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €161 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syneos Health  (FRA:8IN) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Syneos Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=40.00/0.713
=56.10

Syneos Health's share price for today is €40.00.
Syneos Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.713.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Syneos Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Syneos Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health (FRA:8IN) Business Description

Traded in Other Exchanges
N/A
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Syneos Health (FRA:8IN) Headlines

No Headlines